Nanthealth and Nantomics to Present Data on the Frequency of Non-expressed Variants Tested by Standard NGS Panel at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

by Jen Hodson | Jun 4, 2018 | Press Releases

Results to be presented during the tumor biology session at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting  CHICAGO, IL – June 4, 2018 – NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading...

NANT Receives FDA Authorization for New Clinical Trials with Personalized, Next-Generation Neoepitope Cancer Vaccine

by Jen Hodson | Jun 3, 2018 | Press Releases

The FDA has authorized a phase 1 study for an investigational Neoepitope Yeast Vaccine, YE-NEO-001, in patients previously treated for cancer CHICAGO – June 3, 2018 — NANT, a technology and research company connecting breakthrough research in biology, healthcare and...

NantOmics to Present Data for Mutational Processes and Response to Neoadjuvant Chemotherapy in Breast Cancer at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

by Jen Hodson | Jun 2, 2018 | Press Releases

Genomic sequence analysis linked response to neoadjuvant therapy including Abraxane in triple negative breast cancer (TNBC) to a unique molecular signature.  The  results to be presented during the breast cancer session at ASCO 2018 Annual Meeting CHICAGO, IL – June...

NantOmics to Report Data on Cardiac Function in Sarcoma Patients Receiving Aldoxorubicin with Doxorubicin Equivalent Doses Over 1000 mg/m2 at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

by Jen Hodson | Jun 2, 2018 | Press Releases

Results to be presented during the sarcoma session at the ASCO 2018 Annual Meeting CHICAGO, IL – June 2, 2018 – NantWorks, LLC today announced that its affiliate company, NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks ecosystem of...

NantOmics to Present Analysis on Potential Therapeutic Target in Adenoid Cystic Carcinoma at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

by Jen Hodson | Jun 2, 2018 | Press Releases

Results to be presented during the head and neck cancer session at the ASCO 2018 Annual Meeting CHICAGO, IL – June 2, 2018 – NantWorks, LLC today announced that its affiliate company, NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks...

NantOmics Announces Study Showing Signature Analysis that Reveals Three Distinct Classifications of Skin Cancer Known as Sebaceous Carcinoma

by Jen Hodson | May 21, 2018 | Press Releases

May 21, 2018 Research published on May 14 in the peer-reviewed journal Nature Communications shows for the first time three distinct classifications of sebaceous carcinoma, a rare and sometimes deadly form of skin cancer. Culver City, CA – May 21, 2018 – NantOmics,...